Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
Intel share price gains over 10% on NYSE after chipmaking rivals TSMC, Broadcom eye potential split deals
Stock Market

Intel share price gains over 10% on NYSE after chipmaking rivals TSMC, Broadcom eye potential split deals

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to

India rupee to take cues from dollar path, tariff reaction; bonds to eye liquidity moves
Stock Market

India rupee to take cues from dollar path, tariff reaction; bonds to eye liquidity moves

By Dharamraj Dhutia and Nimesh Vora MUMBAI, Feb 17 (Reuters) – The Indian rupee’s direction this week will be shaped by the dollar’s reaction to

Singapore PM Lawrence Wong, CII Core Group eye stronger India-Singapore partnership
Business

Singapore PM Lawrence Wong, CII Core Group eye stronger India-Singapore partnership

Singapore Prime Minister Lawrence Wong highlighted the immense potential for deeper collaboration between India and Singapore in skills training and the digital economy, underscoring their

Japanese firms eye India as part of ‘China Plus One’ strategy
Business

Japanese firms eye India as part of ‘China Plus One’ strategy

Post the Covid-19 pandemic, Japanese companies are eyeing India as a base as they adopt the ‘China Plus One’ strategy to diversify their manufacturing and

Investors eye FIIs flows, currency trends, US tariff speculations, and key domestic data in upcoming week
Stock Market

Investors eye FIIs flows, currency trends, US tariff speculations, and key domestic data in upcoming week

Mumbai [India], : Market participants in the coming week starting from Monday are expected to react to the Foreign Institutional Investments flow, currency movement, speculation

Glenmark USA launches generic eye drops for Glaucoma treatment 
Business

Glenmark USA launches generic eye drops for Glaucoma treatment 

Glenmark Pharmaceuticals Inc., USA announced today the launch of Latanoprost Ophthalmic Solution, 0.005 per cent, a generic version of Upjohn’s Xalatan. This marks the company’s